Huoyou Long

Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region–Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib

Xiaomei Ren, Xiaofen Pan, Zhang Zhang et al. · Journal of Medicinal Chemistry · 2013 · 181 citations · Full text

Medicine, Oncology, Pharmacology +13

New benzimidazole-2-urea derivates as tubulin inhibitors

Wenna Wang, Huimin Cheng, Li Tan et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 45 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

<i>N</i>-(3-Ethynyl-2,4-difluorophenyl)sulfonamide Derivatives as Selective Raf Inhibitors

Yingjun Li, Huimin Cheng, Zhang Zhang et al. · ACS Medicinal Chemistry Letters · 2015 · 39 citations · Full text

Medicine, Medicinal Chemistry, Oncology +10

Design, Synthesis, and Biological Evaluation of 3-(1<i>H</i>-1,2,3-Triazol-1-yl)benzamide Derivatives as Potent Pan Bcr-Abl Inhibitors Including the Threonine³¹⁵→Isoleucine³¹⁵ Mutant

Yupeng Li, Mengjie Shen, Zhang Zhang et al. · Journal of Medicinal Chemistry · 2012 · 38 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14